
Join to view full profile
55 Lake Ave NWorcester, MA 01655
Phone+1 508-334-3550
Fax+1 774-442-9130
Dr. Hemming is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2014 - 2017
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2012 - 2015
Harvard Medical SchoolClass of 2012
Harvard UniversityPhD, 2007
Certifications & Licensure
MA State Medical License 2015 - 2027
NH State Medical License 2024 - 2024
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Fibroblast growth factor receptor inhibition for succinate dehydrogenase-deficient gastrointestinal stromal tumors: a phase 2 trial.Priscilla Merriam, James J Morrow, Emanuele Mazzola, Nicole L Solimini, Prafulla C Gokhale
Nature Medicine. 2026-06-01 - 7 citationsASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs.Ewa Sicinska, Vijaya S R Kola, Joseph A Kerfoot, Madeleine L Taddei, Alyaa Al-Ibraheemi
Cancer Research. 2024-07-15 - 24 citationsConcurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST.Inga-Marie Schaefer, Matthew L Hemming, Meijun Z Lundberg, Matthew P Serrata, Isabel Goldaracena
British Journal of Cancer. 2022-11-01
Journal Articles
- Translational Insights into Gastrointestinal Stromal Tumor and Current Clinical AdvancesM C Heinrich, S George, M L Hemming, Annals of Oncology
Grant Support
- Defining clinically relevant transcriptional networks in gastrointestinal stromal tumorUNIV OF MASSACHUSETTS MED SCH WORCESTER2020–2025
- Defining clinically relevant transcriptional networks in gastrointestinal stromal tumorUNIV OF MASSACHUSETTS MED SCH WORCESTER2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









